Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in South Korea / NCT06158360
Recruiting Observational

An Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T)

NCT06158360 · tracked via the Priya Life Science South Korea tracker
Sponsor
Ilsan Cha hospital
Phase
Observational
Started
2023-12-01
Last updated
2026-03-30

Condition(s) studied

Thyroid Cancer

Study summary

This observational study aimed to evaluate the safety and efficacy of postoperative management in patients with thyroid cancer who received subtotal or total thyroidectomy.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * 19 years of age or older * Those who have been confirmed to have a malignant tumor of the thyroid gland by biopsy or imaging * Subjects who have undergone partial thyroidectomy or total resection within 1 month * Those who have agreed to the implementation of Chinese medicine treatment * The Eastern Cooperative Oncology Group(ECOG) performance status 0-3 * Those who understand the content of the study and agree to participate in the study Exclusion Criteria: * ○ When it is judged that other diseases other than cancer (dementia, cerebrovascular disease, severe organ failure, etc.) may have a significant effect on the decline of physical function * When it is judged that the life expectancy is less than 3 months and sufficient follow-up cannot be carried out * When emergency or major surgery or surgical intervention is required that takes precedence over postoperative treatment * Pregnant and lactating women * Other researchers who are judged to be unsuitable for research

Primary outcome measure(s)

  • THYCA-QoL score at the time of discharge (1w) of hospitalization performed for postoperative management purposes — At the end of week 1(each cycle is 7days)
    The THYCA-QoL is a health-related quality of life questionnaire developed for thyroid cancer and thyroid cancer survivors using methodologically proven standard guidelines and validated questionnaires to improve symptoms, treatment, follow-up and disease experience in thyThe THYCA-QoL is a health-related quality of life questionnaire developed for thyroid cancer and thyroid cancer survivors using methodologically proven standard guidelines and validated questionnaires to improve symptoms, treatment, follow-up and disease experience in thyroid cancer survivors. roid cancer survivors.

Trial sites (3)

FacilityCityRegionStatus
Bundang Cha Hospital Gyeonggi-do South Korea Recruiting
Ilsan Cha Hospital Gyeonggi-do South Korea Recruiting
Gangnam Cha Hospital Seoul South Korea Recruiting

More Ilsan Cha hospital trials in South Korea

Pharmacopuncture for Aromatase Inhibitor Induced Arthralgia (AIA) Recruiting
Viscum Album for TNBC on Adjuvant Pembrolizumab Recruiting
Hemodynamic Effects of Remimazolam vs Propofol During Robot-assisted Gynecologic Surgery Starting soon
Nasal Steam Therapy for Post-extubation Respiratory Events Recruiting

Other trials for the same condition

Active Surveillance for Low-risk Papillary Thyroid Carcinoma Enrolling by invitation
Active Surveillance on Papillary Thyroid Microcarcinoma Active, not recruiting
Nasal Steam Therapy for Post-extubation Respiratory Events Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06158360 on ClinicalTrials.gov ↗ ← All trials in South Korea